Management of hypertensive crises in the elderly

被引:11
作者
Alshami, Abbas [1 ,2 ]
Romero, Carlos [1 ,3 ]
Avila, America [1 ,4 ]
Varon, Joseph [5 ,6 ,7 ]
机构
[1] Dorrington Med Associates, Houston, TX USA
[2] Univ Baghdad, Coll Med, Baghdad, Iraq
[3] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico
[4] Univ Durango Santander, Hermosillo, Sonora, Mexico
[5] Univ Texas Hlth Sci Ctr Houston, 2219 Dorrington St, Houston, TX 77030 USA
[6] Univ Texas Med Branch Galveston, Galveston, TX USA
[7] United Gen Hosp, United Mem Med Ctr, Crit Care Serv, Houston, TX USA
关键词
Beta-blockers; Calcium channel blockers; Clevidipine; Elderly; Esmolol; Fenoldopam; Hypertensive crises; Labetalol; Nicardipine; Nitroprusside; ACTING CALCIUM-ANTAGONIST; CARDIAC-SURGERY PATIENTS; SODIUM-NITROPRUSSIDE; BLOOD-PRESSURE; PERIOPERATIVE HYPERTENSION; INTRAVENOUS NICARDIPINE; CLINICAL-EVALUATION; PRACTICE PATTERNS; DRUG-THERAPY; DOUBLE-BLIND;
D O I
10.11909/j.issn.1671-5411.2018.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertensive crises are elevations of blood pressure higher than 180/120 mmHg. These can be urgent or emergent, depending on the presence of end organ damage. The clinical presentation of hypertensive crises is quite variable in elderly patients, and clinicians must be suspicious of non-specific symptoms. Managing hypertensive crises in elderly patients needs meticulous knowledge of the pathophysiological changes in them, pharmacological options, pharmacokinetics of the medications used, their side effects, and their interactions with other medications. Clevidipine, nicardipine, labetalol, esmolol, and fenoldopam are among the preferred choices in the elderly due to their efficacy and tolerability. Nitroprusside, hydralazine, and nifedipine should be avoided, unless there are no other options available, due to the high risk of complications and unpredictable responses.
引用
收藏
页码:504 / 512
页数:9
相关论文
共 87 条
  • [81] Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass
    Vuylsteke, A
    Milner, A
    Ericsson, H
    Mur, D
    Dunning, J
    Jolin-Mellgård, Å
    Nordlander, M
    Latimer, R
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2000, 85 (05) : 683 - 689
  • [82] Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT)
    Vuylsteke, Alain
    Vincent, Jean-Louis
    de La Garanderie, Didier Payen
    Anderson, Frederick A.
    Emery, Leigh
    Wyman, Allison
    Rushton-Smith, Sophie
    Gore, Joel M.
    [J]. CRITICAL CARE, 2011, 15 (06)
  • [83] INTRAVENOUS NICARDIPINE FOR THE TREATMENT OF SEVERE HYPERTENSION
    WALLIN, JD
    COOK, ME
    BLANSKI, L
    BIENVENU, GS
    CLIFTON, GG
    LANGFORD, H
    TURLAPATY, P
    LADDU, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03) : 331 - 338
  • [84] Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]
  • [85] SELECTIVE DOPAMINE-1 AGONIST THERAPY IN SEVERE HYPERTENSION - EFFECTS OF INTRAVENOUS FENOLDOPAM
    WHITE, WB
    RADFORD, MJ
    GONZALEZ, FM
    WEED, SG
    MCCABE, EJ
    KATZ, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (05) : 1118 - 1123
  • [86] WOOD M, 1987, ANESTH ANALG, V66, P132
  • [87] Hypertensive urgencies and emergencies - Prevalence and clinical presentation
    Zampaglione, B
    Pascale, C
    Marchisio, M
    CavalloPerin, P
    [J]. HYPERTENSION, 1996, 27 (01) : 144 - 147